Concepedia

Publication | Open Access

Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial

DOIFull Paper Access

262

Citations

26

References

2020

Year

David Z.I. Cherney, Claire C. J. Dekkers, Sean J. Barbour, Daniel C. Cattran, Abdul Halim Abdul Gafor, Peter J. Greasley, Gozewijn D. Laverman, Soo Kun Lim, Gian Luca Di Tanna, Heather N. Reich,
The Lancet Diabetes & Endocrinology

References

YearCitations

Page 1